Genomic Exploration of Insulin-like Proteins in Arthrospira platensis SPKY1
by Yuvarani K, Kathireshan AK*
Department of Microbiology, School of life sciences, Vels University, Pallavaram, Chennai, Tamilnadu, India
*Corresponding author: Kathireshan AK, Department of Microbiology, School of Life Sciences, Vels University, Pallavaram, Chennai, Tamil Nadu, India.
Received Date: 3 February 2024
Accepted Date: 8 February 2024
Published Date: 19 February 2024
Citation: Yuvarani K, Kathireshan AK (2024) Genomic Exploration of Insulin-like Proteins in Arthrospira platensis SPKY1. Curr Res Cmpl Alt Med 8: 231. https://doi.org/10.29011/2577-2201.100231
Abstract
The prevalence of diabetes, especially type 2 diabetes (T2DM), has reached epidemic levels globally, significantly impacting populations across various countries, including India. This study aimed to explore the potential of A. platensis SPKY1 in producing insulin as a cost-effective and sustainable alternative to traditional insulin sources. Water samples were collected from the Ennore estuary in Chennai, India, and A. platensis SPKY1 was isolated and identified. Growth studies revealed A. platensis SPKY1 as the most potent species in terms of growth rate and biomass accumulation. Screening for insulin presence among isolated strains showed A. platensis SPKY1 to exhibit insulin production of 15 µg/g of dry biomass. This finding was further confirmed through protein estimation, SDS-PAGE, 2D gel electrophoresis, and MALDI, revealing a 6 kDa band similar to previous insulin identification studies. Whole genome sequencing of A. platensis SPKY1 confirmed the presence of genes encoding insulin-like proteins, with eight insulinase family proteins identified. HPLC analysis confirmed the presence of insulin in A. platensis SPKY1, with a retention time of 6.79 minutes. This study underscores the potential of A. platensis SPKY1 as a viable source for insulin production, offering advantages such as minimal cost, easy availability, and no reported side effects. Further research and development in this direction could contribute to addressing the growing demand for insulin, particularly in regions with a high prevalence of diabetes, providing a breakthrough in insulin production and accessibility.
Keywords: Diabetes; Insulin; Spirulina; Arthrospira; Antidiabetic; Antiglycemic
Introduction
Diabetes emerged as a significant global health concern in the 21st century, significantly contributing to mortality rates. Data from the International Diabetes Federation (IDF) revealed substantial diabetes prevalence in key countries, including China with 116.4 million, India with 77.0 million, and the United States of America with 31.0 million cases. This rise had reached epidemic levels, with 90% of cases being type II, and it notably affected younger populations [1]. The Global Burden of Disease study, conducted across 195 countries and territories, highlighted a significant surge in the incidence (11.6 million) and prevalence (264.8 million) of diabetes from 1990 to 2017 [2].
In India, the prevalence of diabetes has steadily risen over the past 30 years, significantly contributing to the global burden of the disease. A 2017 study by the Indian Council of Medical Research revealed that the prevalence of diabetes among all age groups increased by 64.3% from 1990 to 2016 [3]. According to the India State-Level Disease Burden Initiative Diabetes study, Tamil Nadu exhibited the highest prevalence in 2016, followed by Kerala, Delhi, Punjab, Goa, and Karnataka [4]. The largest national study conducted in 15 states of India reported diabetes prevalence ranging from 4.3% to 13.6%, with higher rates in rural areas (5.8% to 15.5%) than urban areas (3.5% to 8.7%) [5]. Additionally, the prevalence of type 2 diabetes was higher among Asian Indians residing in Chennai (38%) compared to those in San Francisco and Chicago, USA (24%) [6]. Data from the populationbased representative Center for Cardio-metabolic Risk Reduction in South Asia (CARRS) Study indicated that six out of ten adults in South Asian cities were either diagnosed with diabetes or had pre-diabetes [7]. This epidemic led to a growing demand for antidiabetic medications, including insulin therapy.
Insulin therapy is essential in managing diabetes, as it is required by all individuals with type 1 diabetes and the majority of those with type 2 diabetes (T2DM) at some point during their treatment. Approximately 4 out of 10 patients with T2DM in India utilized only insulin or a combination of insulin and oral anti-diabetic medications (OADs) [8]. Certain insulin products in India were included in both national and state essential medicines lists (EMLs), allowing for their provision free of charge in public-sector health facilities [9]. However, a survey conducted in Delhi found that the mean availability of recombinant human and analogue insulin in the private sector was significantly lower, at 44.4% and 13.1%, respectively, which were much lower than the WHO recommendation of 80% [10]. Initially, insulin was derived from animals and developed in various formulations. To meet the demand, the production of recombinant human insulin and analogue products has been facilitated through the use of genetically modified microbes (GMOs) [11,12]. Indian individuals tended to prefer private healthcare sectors for diabetes management. However, all insulin and analogues were produced abroad by foreign companies and then imported into the Indian market, making them inaccessible to millions due to poor availability and unaffordable prices [13].
People with diabetes frequently preferred for complementary and alternative medicine (CAM) due to various reasons, including its lower cost, higher medication adherence, perceived lack of side effects, easy availability, and natural origins. A review highlighted alternative sources of insulin beyond the pancreas [14]. Studies showed that Spirulina supplementation could decrease blood sugar levels [15], HbA1c levels [16], glucose-6phosphate activity [17], oxidative stress [18], lipid profiles [19], triglycerides, and cholesterol [20], amylase activity [21] body weight, and waist circumference [22]. Studies also reported that Spirulina supplementation increased insulin levels [23-26]. Thus, the objective of this study is to isolate and identify the nucleotide sequence encoding the insulin gene and produce insulin in Spirulina sp.
Materials and methods
Study Area
The Ennore estuary, located north of Chennai and extending beneath the Kathivakkam region, occupied a precise geographical area at Latitude 13.23N and Longitude 80.32E with a shallow depth of 2-5 meters. It received waters from the Kortalaiyar River, Buckingham Canal, and several small channels. Mangroves present nearby helped in the decomposition of organic matter through microbial processes.
Water collection
Water samples of about 2 liters were collected from the Ennore estuary using clean plastic containers at a depth of approximately 10 cm in three different collection areas. Initially, the water temperature and pH were measured using a centigrade thermometer and a digital pH meter, respectively. Subsequently, the water samples were preserved in 5% neutralized formalin and stored in a refrigerator for further investigations.
Isolation and identification
Algae were isolated from the water samples through serial dilution, and these samples were streaked on petri plates containing agar and Zarrouk medium. Colonies of algae that grew were isolated and sub-cultured onto fresh agar plates. These colonies were then inoculated into freshly prepared liquid culture medium. Arthrospira sp. present in the water samples were identified based on their morphological characteristics such as color of scum, fibrous nature, floating or deposited filaments, presence of heterocysts, and shape, using both low and high power objectives of the compound microscope. The prominence of a species in the Arthrospira community can be assessed quantitatively by frequency (F). Frequency is the percentage of sites at which the species occurred and calculated by the formula:
Unialgal cultures
To ensure that different species of organisms did not exist in the isolated cultures, the mother cultures originating from single algal colonies were used for further investigations. However, these seed cultures still contained bacteria, leading to a risk of contamination and potential loss of the prepared mother cultures. To obtain bacterial-free cultures of Arthrospira sp, small portions of algae were immersed in chlorinated water (25mg/100ml) for 5 minutes [27]. Subsequently, algae samples were centrifuged at 10,000 rpm at room temperature for 5 minutes, and the supernatant was discarded. The algae pellet was then washed twice with distilled water to remove excess chlorine, and finally, the pellet was inoculated into freshly prepared culture medium. All further experiments were conducted using these cultures, which served as the seed cultures for the biomass production of Arthrospira sp.
Estimation of cell population by direct microscopic method
Conn’s direct microscopic count method involves counting the number of cells in several microscopic fields to estimate the algae cell population. First, 0.01ml of culture was added to a glass slide covering an area of about 1 square centimeter, and it was spread uniformly. The glass slide was then observed with a cover glass using a microscope [28].
Biomass estimation
The harvesting process involved centrifuging 100ml of cultures at 5,000rpm at room temperature. After centrifugation, the supernatant was carefully discarded. The resulting pellet was washed twice by centrifugation with distilled water to remove any salts present to the pellet. Subsequently, the pellet was dried at room temperature, and the dry weight of the algal biomass was calculated in terms of grams per liter (g/l) [29].
Protein Estimation
10mg of dried algal powder was combined with 10ml of hot trichloroacetic acid (TCA) (55ºC) in a test tube and left to incubate at room temperature for 5 minutes. After centrifugation, the supernatant was removed, and the pellet was left overnight at room temperature with 1N NaOH. Subsequently, 4ml of alkaline reagent was added to 0.1ml of the pellet to dissolve the TCA-precipitated proteins. The solution was left at room temperature for 3 minutes. Following this, 0.5ml of Folin’s reagent was added to all test tubes and mixed for 5 minutes. 1N NaOH served as the blank solution. Various concentrations (10-100mg) of bovine serum albumin were used as standards. After 30 minutes of incubation at room temperature, the absorbance of all test tubes was measured. The protein content in 10mg of algae was determined using a standard curve [30].
SDS-PAGE
A 12% SDS-PAGE gel mixture was prepared and run, followed by staining with Coomassie Blue. The composition of the separating gel (10 ml) was as follows: MilliQ water (3.3 mL), 30% acrylamide (4 mL), 1.5M Tris pH 8.8 (2.5 mL), 10% SDS (0.1 mL), 10% APS (0.1 mL), and TEMED (0.004 mL). The composition of the stacking gel (4 ml) was as follows: MilliQ water (2.7 mL), 30% Acrylamide (0.67 mL), 1M Tris-pH 6.8 (0.5 mL), 10% SDS (0.04 mL), 10% APS (0.04 mL), and TEMED (0.004 mL). The gel was run with 10 μl of samples at 150 V and 260 A for 2 hours before staining with Coomassie Brilliant Blue G250 [31].
2D- Gel electrophoresis
Two-dimensional gel electrophoresis of processed proteins (100 μg) was conducted using the following steps: Firstly, 13 cm IPG strips with a pH range of 3-10 (GE Healthcare, Uppsala, Sweden) were employed in the first dimension. The proteins underwent focusing for a total of 40,000 Vhs at a constant temperature of 20°C under a linear voltage ramp after passive IPG rehydration. The isoelectric focusing (IEF) conditions were as follows: 100 V step-n-hold for 1 hour, 300 V step-n-hold for 2 hours, 1000 V gradient for 1 hour, 5000 V gradient for 3 hours, and 5000 V step-n-hold for 7 hours. Following the IEF, each IPG strip was sequentially incubated in equilibration buffer containing 2% DTT (dithiothreitol) and then in another buffer with 2.5% iodoacetamide replacing DTT. Finally, the second dimension polyacrylamide gel electrophoresis (PAGE) (12.5%) was carried out in an SE600 apparatus (GE Healthcare, Uppsala, Sweden) initially at 1 W/gel for 1 hour, followed by 13 W/gel for 3 hours.
Protein Identified through MALDI
The process of in-gel trypsin digestion was performed for all the selected spots from the 2D gels following the previously described protocol [32]. The extracted peptides were subsequently analyzed via mass spectrometry using a SHIMADZU MALDI 7090 (TOF/TOF MS) instrument. The acquisition parameters were set as follows: the lyophilized samples were first diluted in 8 μL of 50:50 (ACN:Water with 0.1% FA). These samples were then vortexed and approximately 0.7 μL in volume was spotted onto a stainless-steel target plate. The CHCA matrix, prepared in a concentration of 50/50 (ACN/Water with 0.1% TFA), was then spotted above the sample spot and air-dried. The analysis was conducted in Reflectro Mode with a mass range of 1-5000 Da.
Whole genome sequencing and Insulin gene prediction
DNA was extracted from the algal powder, and the purified DNA was analyzed for quality using a Qubit fluorometer. Whole Genome Sequencing was conducted using Next Generation Sequencing technology. Library preparation was performed using a specific kit from Illumina, and adapters were added to facilitate sequencing. The quality of the prepared library was assessed using a Bioanalyzer, followed by deep sequencing on the Illumina platform with a minimum of 150X2 paired-end reads. Demultiplexing and FASTQ conversion were carried out, and the raw data were evaluated using an in-house quality control module.
The assembly of the genome was generated from the clean data using masurca version 4.1.0. Repeat classification and masking were performed using Repeat Modeler Version 2.0.1 and Repeat Masker version 4.1.1, respectively. Gene prediction was conducted using AUGUSTUS (version 3.4.0). Protein sequences obtained from the gene prediction were utilized for homology search (BLAST) using the AAA59172.1 insulin sequence from Homo sapiens.
Biomass Harvesting
The biomass was harvested on the 20th day from the inoculum using the filter paper method, and the biomass slurry was washed twice with distilled water by centrifugation (3000 rpm) to remove excess salts. The filtered biomass was then dried at room temperature for 24 hours. After drying, the dried algal flakes were ground in a mixer to obtain fine algal powder, which was stored at 4°C in plastic containers for further analysis.
Extraction of Insulin
To extract insulin from the biomass, 5g of biomass was ground with a homogenized solution consisting of 2 mL of distilled water (DW), 10 mL of 95% ethanol, and 0.72 mL of concentrated sulphuric acid. The mixture was thoroughly mixed for 20 minutes. Then, an additional solution of 13 mL distilled water and 40 mL of 95% ethanol was added, and the pH was adjusted to 1.7 using sulphuric acid. The resulting suspension was filtered using Whatman paper (no. 1), and the pH was readjusted to 3.0 using ammonium hydroxide. To this suspension, a solvent system consisting of 150 mL of 95% ethanol and 200 mL of diethyl ether was added, and the mixture was stored at 4°C for 12 hours. After 12 hours, the supernatant was removed by centrifuging at 3,000×g for 10 minutes. The obtained pellet was washed with an equal ratio of acetone and diethyl ether. The pellet was then dissolved in 25% ethanol, and the pH was adjusted to 8.5. Subsequently, 100 μL of 1 M zinc chloride was added to this solution, and the mixture was incubated at 25°C for 18 hours to precipitate insulin. After 18 hours, the precipitate was collected by centrifugation [33].
HPLC for Insulin
The precipitated insulin sample was dissolved in 500 μL of 0.1% trifluoroacetic acid (TFA) containing 0.1 M EDTA and injected into a C-18 Phenomenex column (250×4.6 mm, 5 μm). The mobile phase consisted of a gradient from 30% to 80% acetonitrile in 0.1% trifluoroacetic acid. The flow rate was set at 1 mL/min, and detection was carried out at 214 nm. Human insulin (50 μg of protein in 500 μL) served as the standard for comparing retention times [34].
Statistical analysis
The experiments conducted in triplicates in this study were subjected to various statistical analyses using SPSS software (Version 25). The mean, standard error mean and P value significance were estimated and the results were inferred for logical interpretations.
Results
The frequency of occurrence of various Arthrospira sp was assessed across all water samples. Among the Arthospira sp. A.platensis exhibited the highest occurrence rates, with frequencies of 94.3%, 87.2% and 92.4% in collection site 1-3 respectively. Additionally, A.maxima emerged as the second most prevalent species with frequencies of 85.6%, 71.1%, and 58. 8% in collection site 1-3 respectively. A.fusifomis with a frequency of 61.0%, 48.2% and 44.2% and A.indica was found to be the least frequent, with frequencies of 7.3%, 6.7%, and 10.1%, respectively.
Table 1 shows the growth studies of four different species of uni-algal cultures over a 20-day period. Across all species, there is a significant increase in cell density and biomass production. A.platensis consistently exhibits the highest cell density and biomass production among the four species at each time point. This suggests that A.platensis is the most potent species in terms of growth rate and biomass accumulation over the observed period. A.maxima, A.indica, and A.fusiformis also shows increasing trends in cell density and biomass production, but at lower levels compared to A.platensis.
5th day 10th day 15th day 20th day (Mean ± SEM) (Mean ± SEM) (Mean ± SEM) (Mean ± SEM) P* Species |
P# |
|||||||||
Cells/ ml) |
Biomass(mg/l) |
Cells/ ml) |
Biomass(g/l) |
Cells/ ml) |
Biomass(g/l) |
Cells/ml) |
Biomass(g/l) |
|||
A.maxima |
122± 5 |
0.15± 0.004 |
133± 8 |
0.32± 0.012 |
227± 6 |
0.71± 0.040 |
700± 12 |
1.12± 0.030 |
0.002 |
0.002 |
A.indica |
170± 8 |
0.09± 0.006 |
200± 5 |
0.28± 0.015 |
240± 7 |
0.83± 0.025 |
580± 6 |
1.02± 0.032 |
0.001 |
0.008 |
A.platensis |
203± 12 |
0.19 ± 0.008 |
410± 4 |
0.63± 0.017 |
606± 5 |
1.05± 0.050 |
1380± 17 |
1.48± 0.021 |
0.001 |
0.001 |
A.fusifomis |
300± 5 |
0.12± 0.002 |
407± 3 |
0.59± 0.010 |
501± 6 |
0.96± 0. 018 |
750± 14 |
1.23± 0.019 |
0.001 |
0.001 |
Each value is a mean of 4 individual analyses with standard error of mean. *- Significance (p<0.05) in cell count at different intervals. #- Significance (p<0.05) in biomass production at different intervals |
Table 1: Growth studies of unialgal cultures of Arthospira sp.
Protein estimation
The protein content of isolated Arthrospira sp. were studied in the lab condition and observed data presented in the Table 2. Among the four Arthrospira sp tested on protein content A.platensis showing the highest mean total protein content, followed by A.maxima and A.indica. A.fusiformis displayed a slightly lower mean total protein content compared to the other species. Since the P value is less than 0.05 there is a significantly different in protein content among the tested Arthrospira sp.
S.No |
Species |
Total Protein content µg/g (Mean ± SD) |
p* |
SDS (6 kDa band) |
2D (6 kDa band) |
Insulin |
1 |
A.maxima |
7.5 ± 0.4 |
0.043 |
Negative |
Negative |
Negative |
2 |
A.indica |
7.0 ± 0.2 |
Positive |
Negative |
Negative |
|
3 |
A.platensis |
7.9 ± 0.5 |
Positive |
Positive |
Positive |
|
4 |
A.fusifomis |
6.7 ± 0.2 |
Negative |
Negative |
Negative |
|
*- Significance (p<0.05) in total protein content among the test Arthrospira sp. |
Table 2: Screening the presence of insulin among the isolated Arthrospira sp.
SDS PAGE
Protein extracted from all isolated Arthrospira sp, were analysed in SDS PAGE and results shows that all the four Arthrospira strains shows different protein profiling. Previous studies shown that insulin were detected at 6kDa in SDS PAGE. Similar 6kDa band was observed in A.indica and A.platensis but it was not detected in A.maxima and A.fusifomis (Figure 1).To further conformationallstrains were taken to 2D gel electrophoresis and MALDI.
1: A.maxima, 2: A.indica, 3: A.platensis, 4: A.fusifomis, M: molecular ladder
Figure 1: Protein profiling of the tested Arthrospira sp by SDS PAGE.
2D gel electrophoresis and MALDI
Extracted proteins from all tested Arthrospira strains were analysed by 2D gel electrophoresis and results shows that all the strains are different in their protein patterns. In contrast to SDS PAGE, 6kDa was observed only in A.platensis and 6kDa found in A.indica by SDS, now apperaed at 9.11kDa. Similar like SDS PAGE, the 6kDa band is also not observed in other two strains (A.maxima and A.fusifomis) by 2D gel electrophoresis (Figure 2).
Analysis of five significant spots including 6kDa in A.platensis were analyse by MALDI-TOF MS and subsequent searching of the PMF data against the databases to identify the proteins reveals the presence of phycocyanin beta chain (1), Histidine kinase (2), Hypothetical protein (3), HNH endonuclease (4), and Cyclic pyranopterin monophosphate synthase (Figure 3). The difficulty in searching for a good match of the protein in the databases might be due to the unavailability of a Arthrospira whole genome sequence.
1: A.maxima, 2: A.indica, 3: A.platensis, 4: A.fusifomis
Figure 2: Protein profiling of the tested Arthrospira sp by 2D gel electrophoresis.
1: Phycocyanin beta chain, 2: Histidine kinase, 3: Hypothetical protein, 4: HNH endonuclease and 5: Cyclic pyranopterin monophosphate synthase.
Figure 3: Protein identification of A. platensis SPKY1 by MALDI.
Whole genome sequencing and Insulin gene prediction
A.platensis SPKY1, which exhibited positive results for insulin via MALDI, underwent whole genome sequencing and was subsequently submitted to NCBI with the Genbank ID: JAWMAM000000000.1. The genome of A. platensis comprises a single, circular chromosome with a size of 5.7 Mb and an average GC content of 54.5%. The genome of A.platensis SPKY1 was predicted to harbor 13,482 protein-coding genes, which can be annotated based on known functions or identified as hypothetical proteins in the UniProt/Swiss-Prot and non-redundant protein databases, respectively. Additionally, the genome sequence was found to contain 43 RNA genes, including 28 tRNA genes and genes encoding rRNA (5S, 16S, 23S).
Table 3 shows the amino acid sequences obtained from the gene prediction were utilized for homology search (BLAST) using the AAA59172.1 insulin sequence from Homo sapiens showed that 4 hypothetical proteins (six residues) shows 100% identity with one BLAST hit with human insulin. Result suggests only partial identity with human insulin and also indicate that four different 6 residues which are 100% matched with human insulin might be present at 6kDa at SDS PAGE, 2D gel, and MALDI reported as hypothetical protein (Figure 4a & b). A.platensis SPKY1 was also reported 8 insulinase family proteins which further the confirming the presence of insulin (Figure 5).
Genbank Accession No |
Query Identical Seq |
Subject Identical Seq |
Protein ID |
Protein Name |
JAWMAM010001280 |
263 PDPAAA 268 |
19 PDPAAA 24 |
MDV7390887.1 |
Hypothetical protein |
JAWMAM010008923 |
32 RREAED 37 |
55 RREAED 60 |
MDV7398747.1 |
Hypothetical protein |
JAWMAM010007148 |
81 GGGPGA 86 |
69 GGGPGA 74 |
MDV7397142 .1 |
Hypothetical protein |
JAWMAM010003156 |
105 PDPAAA 110 |
19 PDPAAA 24 |
MDV7393163.1 |
Hypothetical protein |
Table 3: Insulin like sequence from A.platensis SPKY1 showing significant alignment with Human insulin (Acc No: AAA59172.1, 110aa).
Figure 4a: A.platensis SPKY1 insulin like antigen sequences producing significant alignments with human insulin.
Figure 4b: A.platensis SPKY1 insulin like antigen sequences producing significant alignments with human insulin.
Figure 5: Eight insulinase family proteins from A.platensis SPKY1.
HPLC for Insulin
Insulin isolated from A.platensis was analysed using HPLC and insulin was detected at the retention time of 6.79min respectively and similarly chromatogram was also observed when analysed with human insulin as standard. On the 20th day following inoculation it was observed that A.platensis containing 15.89µg/g of dry biomass (Figure 6).
Figure 6: HPLC analysis of A. platensis SPKY1 insulin and human insulin.
Discussion
Human consumption of Spirulina as food dates back to the Aztec civilization due to its high protein content and other essential nutrients, along with its safety for human consumption without any potential side effects [35,36]. Previous studies have demonstrated the positive impact of Spirulina on various non-communicable diseases, including improvement in lipid profile [37,38], potential anticancer effects [39], alleviation of arthritis symptoms [40], treatment of anemia [41], and management of diabetes [42].
According to Wang et al. [43], lifestyle changes are the primary need for controlling diabetes, but adherence to dietary restrictions and increased physical activity can be challenging for many patients, leading to the use of pharmacological agents such as insulin, which may have side effects limiting their acceptability and efficacy [44]. Studies have also indicated the positive effects of Spirulina as a functional food for individuals with diabetes [45,46]. A study conducted by Anwer et al. (2012) reported the presence of insulin-like protein in sixteen Spirulina sp collected from culture collections [34]. In this study, we isolated Spirulina sp from the natural source (Ennore estuary) to screen for the presence of insulin-like protein. Out of four tested strains, A. platensis SPKY1 showed positive insulin production of 15 µg/g of dry biomass, which is lower than the insulin content reported in previous studies [34]. A study confirmed the presence of insulin by ELISA method in A. maxima but in contrast the A.maxima isolated in this study from Ennore estuary shows negative [47].
Further confirmation of insulin in A. platensis SPKY1 was done by SDS-PAGE, 2DE, and MALDI, which showed similar band patterns (6 kDa) to previous studies [48-50]. However, other studies have reported insulin with molecular weights both less than 6kDa [51-53], and greater than 6 kDa from plant sources [54-56].
All of these studies reported the presence of insulin from plant sources. However, studies on Spirulina supplementation for reducing blood sugar did not identify the exact biomolecules responsible for this anti-diabetic property. Only two studies reported the presence of insulin in Spirulina sp., but these studies not reported whole genome sequencing to identify the insulin gene sequence. In this study, the potentially positive strain A. platensis SPKY1 was subjected to whole genome sequencing and subsequently submitted to NCBI. The genome size of A. platensis SPKY1 was determined to be 5.7 Mb, which is slightly smaller compared to other strains such as A. platensis C1 (6.09 Mb) [57], Arthrospira sp. PCC 8005 (6.23 Mb) [58], and A. platensis NIES39 (6.79 Mb) [59]. In A. platensis SPKY1, a total of 7731 genes coding for hypothetical proteins were observed. Gene prediction revealed four different hypothetical proteins with 6 amino acid residues, which showed 100% identity with Human insulin. Similarly, a study conducted by Anwer et al. 2011 reported 3 residues (44 GER 46) similar to bovine and human insulin with 100% identity in A. platensis [34]. Furthermore, HPLC analysis of insulin extracted from A. platensis SPKY1 showed a retention time of 6.79 minutes and exhibited a similar chromatogram to standard human insulin. Another study reported the retention time of insulin from B. variegate (6.95 minutes) [60], Arabidopsis thaliana seeds (17.2 minutes) [61], and Vigna unguiculata (31.0 minutes) [62].
Insulin remains inaccessible to millions of people due to poor availability and unaffordable prices [11]. The significant price gap between production costs and actual prices raises ethical concerns about the affordability of essential medication for millions with diabetes, especially in low- and middle-income countries. While insulin has traditionally been produced using E. coli bacteria via rDNA technology [63], there is a growing need for alternative sources to reduce production costs.
Exploring alternative production methods, such as using yeast or other microorganisms, is being investigated to create a more cost-effective insulin supply. The study represents the first instance of reporting eight insulinase family proteins from A. platensis SPKY1, thereby confirming the presence of insulin. This presence of insulinase was not reported in previous studies. Insulinase family proteins, which play a role in breaking down insulin, were identified in the cyanobacterium, suggesting a potential involvement in insulin metabolism.
Conclusion
The genomic exploration of insulin from A. plantensis SPKY1 presents a promising tool for insulin production with potential advantages in terms of minimal cost, easy availability, and no side effects. A. plantensis SPKY1 is a sustainable and economically viable alternative for insulin synthesis. Further research and development in this direction may contribute to addressing the rising demand for insulin, particularly in regions with a high prevalence of diabetes, offering a potential breakthrough in insulin production.
Disclosure
Author Contributions: Yuvarani K.: Conceptualization, validation, formal analysis and writing—original draft preparation. Kathireshan AK: Supervision, review and editing. All authors have reviewed and consented to the final version of the manuscript as published.
Funding: This research received no external funding.
Conflicts of Interest: None.
References
- International Diabetes Federation. (2019) IDF Diabetes Atlas (9th ed.). Brussels, Belgium: International Diabetes Federation.
- Lin X, Xu Y, Pan X, Xu J, Ding Y, et al., (2020) Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep 10:14790.
- Indian Council of Medical Research, Public Health Foundation of India, and Institute for Health Metrics and Evaluation (2017) India: Health of the Nation’s States - The India State-Level Disease Burden Initiative. New Delhi: ICMR, PHFI and IHME.
- India State-Level Disease Burden Initiative Diabetes Collaborators (2018) The increasing burden of diabetes and variations among the states of India: The Global Burden of Disease Study 1990–2016. Lancet Glob Health 6: e1352-e1362.
- Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, et al., (2017) Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol 5:585-596.
- Gujral UP, Narayan KM, Pradeepa RG, Deepa M, Ali MK, et al., (2015) Comparing Type 2 Diabetes, Prediabetes, and Their Associated Risk Factors in Asian Indians in India and in the U.S.: The CARRS and MASALA Studies. Diabetes care 38:1312-1318.
- Deepa M, Grace M, Binukumar B, Pradeepa R, Roopa S, et al., (2015) High burden of prediabetes and diabetes in three large cities in South Asia: The Center for cArdio-metabolic Risk Reduction in South Asia (CARRS) Study. Diabetes Res Clin Pract 110:172-182.
- Mohan V, Shah SN, Joshi SR, Seshiah V, Sahay BK, et al., (2014) Current status of management, control, complications and psychosocial aspects of patients with diabetes in India: Results from the DiabCare India 2011 Study. Indian J Endocrinol Metab 18:370-378.
- World Health Organization (2015) India: National list of essential medicines. WHO Essential Medicines and Health Products Information Portal.
- Sharma A, Kaplan WA (2016) Challenges constraining access to insulin in the private-sector market of Delhi, India. BMJ Glob Health 1:e000112.
- Beran D, Ewen M, Laing R (2016) Constraints and challenges in access to insulin: A global perspective. Lancet Diabetes Endocrinol 4:275-285.
- Lu CY, Emmerick IC, Stephens P, Ross-Degnan D, Wagner AK (2015) Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand. J Pharm Policy Pract 8:7.
- Sharma A, Bhandari P, Neupane D, Kaplan WA, Mishra SR (2018) Challenges constraining insulin access in Nepal - a country with no local insulin production. Int Health 10:182-190.
- Khursheed S, Anwer R, Fatma T (2011) Insulin Like Antigen: Sources Other Than Pancreas. International Journal of Current Pharmaceutical Research.
- Alam A, Siddiqui MA, Quamri A, Fatima S, Roqaiya M, Ahmad Z (2016) Efficacy of Spirulina (Tahlab) in patients of type 2 diabetes mellitus (Ziabetus Shakri): A randomized controlled trial. J Diabetes Metab 7:1-5.
- Simon JP, Baskaran UL, Shallauddin KB, Ramalingam G, Evan Prince S (2018) Evidence of antidiabetic activity of Spirulina fusiformis against streptozotocin-induced diabetic Wistar albino rats. 3 Biotech 8:129.
- Anitha L, Reddy CLK (2007) Antidiabetic property of Spirulina. Diabetologia Croatica 35:29-33.
- Guldas M, Ziyanok-Demirtas S, Sahan Y, Yildiz E, Gurbuz O (2020) Antioxidant and anti-diabetic properties of Spirulina platensis produced in Turkey. Food Science and Technology 41:615-625.
- Rahnama I, Arabi SM, Chambari M, Bahrami LS, Hadi V, et al., (2023) The effect of Spirulina supplementation on lipid profile: GRADEassessed systematic review and dose-response meta-analysis of data from randomized controlled trials. Pharmacol Res 193:106802.
- Hernández-Lepe MA, Wall-Medrano A, López-Díaz JA, JuárezOropeza MA, Hernández-Torres RP, et al., (2019) Hypolipidemic Effect of Arthrospira (Spirulina) maxima Supplementation and a Systematic Physical Exercise Program in Overweight and Obese Men: A DoubleBlind, Randomized, and Crossover Controlled Trial. Mar Drugs 17:270.
- Gheda S, Abo-Shady A, Abdel-Karim O, Ismail G (2021) Antioxidant and Antihyperglycemic Activity of Arthrospira platensis (Spirulina platensis) Methanolic Extract: In vitro and In vivo Study. 61:71-93.
- Szulinska M, Gibas-Dorna M, Miller-Kasprzak E, Suliburska J, Miczke A, et al., (2017) Spirulina maxima improves insulin sensitivity, lipid profile, and total antioxidant status in obese patients with welltreated hypertension: a randomized double-blind placebo-controlled study. Eur Rev Med Pharmacol Sci 21:2473-2481.
- Metwally NS, Maghraby AS, Farra EK, Abd El Bak HH, Farrag ARH, et al., (2015) Efficiency of the algae Spirulina platensis as antidiabetic agent. World J Pharm Res 4:18-54.
- Hozayen WG, Mahmoud AM, Soliman HA, Mostafa SR (2016) Spirulina versicolor improves insulin sensitivity and attenuates hyperglycemia-mediated oxidative stress in fructose-fed rats. J Intercult Ethnopharmacol 5:57-64.
- Pandey JP, Tiwari A, Mishra G, Mishra RM (2011) Role of Spirulina maxima in the control of blood glucose levels and body weight in streptozotocin induced diabetic male Wistar rats. J algal biomass utln 2:35-37.
- Lee J, Park A, Kim MJ, Lim HJ, Rha YA, et al., (2017) Spirulina extract enhanced a protective effect in type 1 diabetes by anti-apoptosis and anti-ROS production. Nutrients 9:1363.
- Fogg GE (1942) Studies on nitrogen fixation by blue-green algae. I. nitrogen fixation by Anabaena Cylindrica Lemm. J Exp Biol 19:78-87.
- Vonshak A (1986) Laboratory techniques for the cultivation of microalgae. In A. Richmond (Ed.), Handbook of microalgal mass culture 117-145.
- Sivakumar R, Rajendran S (2013) Growth measurement technique of microalgae. Int J Curr Sci 7:52-54.
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265275.
- Laemmli UK, Teaff N, D’Ambrosia J (1974) Maturation of the head of bacteriophage T4. III. DNA packaging into preformed heads. J Mol Biol 88:749-765.
- Ananthi S, Lakshmi N, Paul A, Kumaraswamy A, Mahalingam S (2018) Global Quantitative Proteomics reveal Deregulation of Cytoskeletal and Apoptotic Signalling Proteins in Oral Tongue Squamous Cell Carcinoma. Scientific Reports 8.
- Khanna P, Nag TN, Chandrajaia S, Mohan S (1976) Process for isolation of insulin from plant source. USA Patent No: US3945988A.
- Anwer R, Khursheed S, Fatma T (2011) Detection of immunoactive insulin in Spirulina. Journal of Applied Phycology 24:583-591.
- Dillon JC, Phuc AP, Dubacq JP (1995) Nutritional value of the alga Spirulina. World Rev Nutr Diet 77:32-46.
- Tarantino LM (2003) Agency Response Letter GRAS Notice No. GRN000127.
- Ramamoorthy A, Premakumari S (1996) Effect of supplementation of Spirulina on hypercholesterolemic patients. J Food Sci Technol 33:124-128.
- Mani UV, Desai S, Iyer U (2000) Studies on the long-term effect of Spirulina supplementation on serum lipid profile and glycated proteins in NIDDM patients. Journal of Nutraceuticals, Functional and Medical Foods, 2:25-32.
- Mathew B, Sankaranarayanan R, Nair PP, Varghese C, Somanathan T, et al., (1995) Evaluation of chemoprevention of oral cancer with Spirulina fusiformis. Nutr Cancer 24:197-202.
- Mishra M, Labhe U, Mani UV, Iyer UM, Jani A (2001) The effect of spirulina in the treatment of bronchial asthma. Journal of Nutraceuticals, Functional & Medical Foods 3:53-60.
- Iyer UM, Mani V, Parikh P, Sadliwala A (2000) Effect of spirulina supplementation on blood hemoglobin levels of anemic girls. Journal of Food Science and Technology 37:642–644.
- Hu S, Fan X, Qi P, Zhang X (2019) Identification of anti-diabetes peptides from Spirulina platensis. J Funct Foods 56:333-341.
- Wang B, Mu X-L, Zhao J, Jiang H-P, Li S-S, Yan G, et al., (2020) Effects of lifestyle interventions on rural patients with type 2 diabetes mellitus. World J Diabetes 11:261-268.
- Strain WD, Paldanius P (2018) Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol 17:57.
- Parikh P, Mani U, Iyer U (2001) Role of Spirulina in the control of glycemia and lipidemia in type 2 diabetes mellitus. J Med Food 4:193199.
- Al-Rahbi, B., Sadek, H., Sallam, A., Zakaria, R., & Al-Ghammari, A. (n.d.). International Journal of Food and Nutritional Science 3:1.
- Silva LB, Santos SS, Azevedo CR, Cruz MA, Venâncio TM, et al., (2002) The leaves of green plants as well as a cyanobacterium, red alga, and fungi contain insulin like antigens. Braz J Med Biol Res 35:297-303.
- Oliveira EAA, Machado LTO, Gomes MV, Neto XJ, Pereira CA, et al., (1999) Jack bean seed coat contains a protein with complete sequence homology to bovine insulin. Protein & Peptide Letters 6:15-21.
- Venancio TM, Oliveira AEA, Silva LB, Machado OLT, Fernandes KVS, et al., (2003) A protein with amino acid sequence homology to bovine insulin is present in the legume Vigna unguiculata (cowpea). Braz J Med Biol Res 36:1167-1173.
- Collier E, Watkinson A, Cleland CF, Roth J (1987) Partial purification and characterization of an insulin-like material from spinach and Lemna gibba G3. J Biol Chem 262:6238-6247.
- Nag B, Medicherla S, Sharma SD (2000) Orally active fraction of Momordica charantia, active peptides thereof, and their use in the treatment of diabetes. U.S. Patent No: US6127338A.
- Yuan X, Gu X, Tang J (2008) Purification and characterisation of a hypoglycemic peptide from Momordica charantia L. var. abbreviata ser. Food Chem 111:415-420.
- Joshi BN, Munot H, Hardikar M, Kulkarni AA (2013) Orally active hypoglycemic protein from Costus igneus N. E. Br.: An in vitro and in vivo study. Biochem Biophys Res Commun 436:278-282.
- Khanna P, Jain SC, Panagariya A, Dixit VP (1981) Hypoglycemic activity of polypeptide-p from a plant source. J Nat Prod 44:648-655.
- Rajasekhar MD, Badri KR, Kumar KV, Babu KR, Fatima SS, et al., (2010) Isolation and characterization of a novel antihyperglycemic protein from the fruits of Momordica cymbalaria. J Ethnopharmacol 128:58-62.
- Cryer PE, Davis SN, Shamoon H (2003) Hypoglycemia in diabetes. Diabetes Care 26:1902-1912.
- Cheevadhanarak S, Paithoonrangsarid K, Prommeenate P, Kaewngam W, Musigkain A, et al., (2012) Draft genome sequence of Arthrospira platensis C1 (PCC9438). Stand Genomic Sci 6: 43-53.
- Janssen PJ, Morin N, Mergeay M, Leroy B, Wattiez R, et al., (2010) Genome sequence of the edible cyanobacterium Arthrospira sp. PCC 8005. J Bacteriol 192:2465-2466.
- Fujisawa T, Narikawa R, Okamoto S, Ehira S, Yoshimura H, et al., (2010) Genomic structure of an economically important cyanobacterium, Arthrospira (Spirulina) platensis NIES-39. DNA Res17:85-103.
- Al-Jumaily E, Fakhri S (2015) Phytochemical Estimation of Some Active Molecules and Plant Insulin (Glucokinin) From the Bauhinia variegata Linn.
- Nykiforuk CL, Boothe JG, Murray EW, Keon RG, Goren HJ, et al., (2006) Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. Plant Biotechnol J 4:77-85.
- Venâncio TM, Oliveira AEA, Silva LB, Machado OLT, Fernandes KV, et al., (2003) A protein with amino acid sequence homology to bovine insulin is present in the legume Vigna unguiculata (cowpea). Braz J Med Biol Res 36:1167-1173.
- Walsh G (2005) Therapeutic insulins and their large-scale manufacture. Appl Microbiol Biotechnol 67:151-159.
© by the Authors & Gavin Publishers. This is an Open Access Journal Article Published Under Attribution-Share Alike CC BY-SA: Creative Commons Attribution-Share Alike 4.0 International License. Read More About Open Access Policy.